Lymphoid Neoplasms
📧 Sign up to get email alerts when something new happens for Lymphoid Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)
This document reports a clinical trial update for INTeRCePT 2.0 evaluating dynamic risk profiling in patients with relapsed/refractory lymph…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Adoption of Audio Recording in the Outpatient Supportive Care Center
This clinical trial update describes the adoption of audio recording in an outpatient supportive care center for patients with solid tumors …
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Futibatinib in Patients With Specific FGFR Aberrations [Phase 2]
Taiho Oncology reports a Phase 2 trial of futibatinib in patients with FGFR aberrations across advanced cancers. The study (NCT04189445) was…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: ACY-1215 for Relapsed/Refractory Lymphoid Malignancies [Phase 1, Phase 2]
Clinical trial update for ACY-1215 (ricolinostat) in relapsed/refractory lymphoid malignancies reports Phase 1/2 results; the study has been…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 trial evaluating CMC-544 with allogeneic transplantation for CD22-positive lymphoid malignancies has completed, with results poste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating bortezomib with chemotherapy in lymphoid malignancies undergoing stem cell transplantation; results posted…
-
CLINICAL_TRIALS trial_result · 2018-03-02Clinical Trial Update: Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT [NA]
A completed clinical trial evaluated cyclophosphamide and busulfan as conditioning before allogeneic hematopoietic stem cell transplantation…